ST
ALXN

Spot Trading’s Alexion Pharmaceuticals ALXN Stock Holding History

Spot Trading’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$6.13M Buy
43,678
+6,422
+17% +$872K 0.11% 216
2017
Q2 		$4.53M Buy
+37,256
New +$4.34M 0.09% 262
2015
Q4 		– Sell
-2,796
Closed -$488K – 4234
2015
Q3 		$437K Buy
+2,796
New +$510K ﹤0.01% 2145
2015
Q1 		– Sell
-30
Closed -$5.43K – 4473
2014
Q4 		$6K Hold
30
– – ﹤0.01% 3745
2014
Q3 		$5K Hold
30
– – ﹤0.01% 4141
2014
Q2 		$5K Hold
30
– – ﹤0.01% 4365
2014
Q1 		$5K Sell
30
-345
-92% -$54.9K ﹤0.01% 4016
2013
Q4 		$50K Buy
375
+191
+104% +$22.9K ﹤0.01% 3497
2013
Q3 		$21K Buy
+184
New +$20.2K ﹤0.01% 3772

Other funds holding ALXN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Spot Trading's ALXN Position: Q3 2017 in Review

Spot Trading increased its Alexion Pharmaceuticals (ALXN) stake by 17% in Q3 2017, buying an estimated $872K and bringing the position to 43,678 shares worth $6.13M. The position accounts for 0.11% of the portfolio, ranked #216.

Spot Trading first reported a position in ALXN in Q3 2013 and has held it in 9 quarters since. 595 funds tracked by Wall St. Rank hold ALXN as of Q3 2017.

  • Spot Trading held 43,678 shares of Alexion Pharmaceuticals worth $6.13M as of Q3 2017.
  • Spot Trading bought 6,422 Alexion Pharmaceuticals shares in Q3 2017, an estimated $872K.
  • Alexion Pharmaceuticals made up 0.11% of Spot Trading's portfolio in Q3 2017, its #216 holding.
  • Spot Trading first reported a position in Alexion Pharmaceuticals in Q3 2013 and has held it in 9 quarters since.
  • 595 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.